Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory Trial of ETC-1002 in Hyper-LDL Cholesterolemia
NCT05683340Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bempedoic acid in hypercholesterolemia, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Feb 2023; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT05683340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683340.